Russian Regions With Highest Smoking Rates in 2021

Aug.12.2022
Russian Regions With Highest Smoking Rates in 2021
Novgorod, St. Petersburg, and Krasnodar have the highest number of smokers in Russia according to a digital tagging experiment.

In terms of population, Novgorod Region, St. Petersburg, and Krasnodar Border Zone have the highest number of smokers since the introduction of the electronic cigarette marking experiment at the beginning of this year.


The analysts of the National Digital Label System have drawn these conclusions based on their own statistical data on packaging sales volume and Rosstat data on the number of permanent residents in the Russian Federation.


According to these data, since the beginning of this year, each resident in the Novgorod region has purchased 4.4 packs of cigarettes, while in St. Petersburg the figure stands at 3.96 packs and in the Krasnodar border region, it is 3.42 packs.


The top 10 regions with the highest smoking rates include Magadan Oblast (2.65), Kamchatka Krai (2.09), Sakhalin (1.96), and Ryazan Oblast (1.92), as well as Moscow (1.84), Crimea (1.74), and Sevastopol (1.49).


According to a public opinion poll conducted by VTsIOM in July, 33% of adult citizens in Russia smoke today.


When analyzing the numbers behind the "honesty mark," it should be considered that in terms of tobacco regulation compliance, "smokers" are primarily the most honest and transparent regions. These leaders may not be the most active tobacco consumers, but they are certainly the most law-abiding.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not necessarily reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of its contents. The translation of this article is solely for industry research and exchange.


Due to limitations in the translator's ability, the translated article may not convey the exact meaning of the original. Please refer to the original text for accuracy.


2FIRSTS is fully aligned with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or international statements and positions.


The ownership of compiled information belongs to the original media and author. If any infringement is found, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. 25 Attorneys General Urge Shopify to Block Illegal E-Cigarette Sales
U.S. 25 Attorneys General Urge Shopify to Block Illegal E-Cigarette Sales
California Attorney General Rob Bonta and the City of New York co-led a bipartisan coalition of 25 attorneys general in urging Shopify Inc. to take stronger measures against merchants selling illegal e-cigarettes and other tobacco products through its platform. The letter calls for cooperation between Shopify and U.S. states to address the persistent sale of unapproved vaping products.
Nov.25 by 2FIRSTS.ai
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
A bill endorsing a licensing system for tobacco and nicotine products has been recommended in Russia's State Duma.
Nov.14 by 2FIRSTS.ai
Juul’s San Francisco Headquarters May Be Sold as Debt Talks Advance
Juul’s San Francisco Headquarters May Be Sold as Debt Talks Advance
Real estate firm Affinius Capital is in talks to sell the loan tied to Juul’s San Francisco headquarters, with Madison Capital emerging as a potential buyer. If completed, the deal could lead to a change in ownership six years after Juul first acquired the building, signaling continued asset adjustments amid regulatory pressure.
Oct.23
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.
E-cigarette brand SKE has listed its “30K Pro Max” bundle across multiple UK e-commerce platforms. The 2-in-1 device features dual flavors with a twist-to-switch design, draw activation, and mesh heating, with a claimed total of up to 30,000 puffs. Across several channels, single-unit pricing ranges from about £8.99 to £10.99.
Oct.24 by 2FIRSTS.ai
Product | NEXA FLEX Releases “Built in the USA” Version, Says All Flavors Are Tailored for Adult U.S. Users
Product | NEXA FLEX Releases “Built in the USA” Version, Says All Flavors Are Tailored for Adult U.S. Users
NEXA has introduced a disposable e-cigarette, NEXA FLEX, which is promoted as “Built in the USA,” highlighting domestic production and flavors developed for adult U.S. vaping consumers. The device retains features such as a transparent e-liquid chamber, Normal/Turbo dual modes, and up to 40,000 puffs, and is scheduled to launch in late November in Texas. Other brands, including SKE and FASTA, have also recently released products labeled as “Made in the USA” or “U.S.-assembled.”
Nov.20 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai